- Home
- ATHA vs GIGM Comparison
ATHA vs GIGM Comparison
Compare ATHA & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- GIGM
- Stock Information
- Founded
- ATHA 2011
- GIGM 1998
- Country
- ATHA United States
- GIGM Taiwan
- Employees
- ATHA N/A
- GIGM N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- GIGM Computer Software: Programming Data Processing
- Sector
- ATHA Health Care
- GIGM Technology
- Exchange
- ATHA Nasdaq
- GIGM Nasdaq
- Market Cap
- ATHA 15.7M
- GIGM 16.1M
- IPO Year
- ATHA 2020
- GIGM 2000
- Fundamental
- Price
- ATHA $0.37
- GIGM $1.43
- Analyst Decision
- ATHA Buy
- GIGM
- Analyst Count
- ATHA 4
- GIGM 0
- Target Price
- ATHA $11.25
- GIGM N/A
- AVG Volume (30 Days)
- ATHA 293.7K
- GIGM 7.0K
- Earning Date
- ATHA 08-12-2025
- GIGM 07-31-2025
- Dividend Yield
- ATHA N/A
- GIGM N/A
- EPS Growth
- ATHA N/A
- GIGM N/A
- EPS
- ATHA N/A
- GIGM N/A
- Revenue
- ATHA N/A
- GIGM $3,250,000.00
- Revenue This Year
- ATHA N/A
- GIGM N/A
- Revenue Next Year
- ATHA N/A
- GIGM N/A
- P/E Ratio
- ATHA N/A
- GIGM N/A
- Revenue Growth
- ATHA N/A
- GIGM N/A
- 52 Week Low
- ATHA $0.22
- GIGM $1.28
- 52 Week High
- ATHA $3.67
- GIGM $1.80
- Technical
- Relative Strength Index (RSI)
- ATHA 47.14
- GIGM 47.32
- Support Level
- ATHA $0.34
- GIGM $1.40
- Resistance Level
- ATHA $0.51
- GIGM $1.60
- Average True Range (ATR)
- ATHA 0.05
- GIGM 0.04
- MACD
- ATHA -0.01
- GIGM 0.00
- Stochastic Oscillator
- ATHA 25.41
- GIGM 15.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.